Teleflex Saham

Teleflex Rule of 40

Rule of 40 dari Teleflex (TFX) pada 23 Agu 2026 adalah -21,77 %. Tahun sebelumnya, Rule of 40 adalah 7,67 % — perubahan sebesar -383,95% (lebih rendah).

Rule of 40

-21,77 %

YoY

-383,95%

Terakhir Diperbarui:

Rule of 40 dari Teleflex adalah 2026 -21,77 % . Rule of 40 dari Teleflex adalah 2025 7,67 % . Menurun -383,95% lebih rendah dibandingkan dengan tahun sebelumnya.

Sejarah Teleflex Rule of 40

  • 3 tahun

  • 10 tahun

  • 25 Tahun

  • Maks

Rule of 40
Date
Rule of 40
1 Jan 2018
27,21 USD
1 Jan 2019
22,47 USD
1 Jan 2020
14,43 USD
1 Jan 2021
33,09 USD
1 Jan 2022
17,25 USD
1 Jan 2023
23,59 USD
1 Jan 2024
7,67 USD
1 Jan 2025
-21,77 USD
Sejarah Teleflex Rule of 40
TAHUNRule of 40YoY
-21,77 %-383,95%
7,67 %-67,50%
23,59 %+36,82%
17,25 %-47,89%
33,09 %+129,30%
14,43 %-35,76%
22,47 %-17,45%
27,21 %-15,59%
32,24 %+58,63%
20,32 %+28,50%
15,82 %
Access this data via the Eulerpool API

Teleflex Analisis saham

Apa yang dilakukan Teleflex? Teleflex Inc. is a global company founded in 1943. The company is headquartered in Wayne, Pennsylvania, USA and operates in over 40 countries worldwide. It is a leading provider of medical devices, instruments, and accessories for various applications in clinical practice and patient care. The business model of Teleflex is based on the manufacturing and marketing of medical devices and instruments, particularly in the areas of anesthesia, vascular access, interventional medicine, pulmonary and thoracic surgery, urological care, cardiovascular diagnostics, and surgery. The company works closely with medical professionals and clinicians to develop high-quality products that meet the needs of patients and doctors. Teleflex is divided into several business segments, including angiography/diagnostics, anesthesia, oncology, vascular intervention, pulmonology, surgery, and urology. Each of these segments offers a wide range of products and solutions specifically tailored to the needs of doctors and patients. In the angiography/diagnostics segment, Teleflex offers a variety of products that can be used for the diagnosis and treatment of cardiovascular diseases and other medical conditions. These include catheters, guide wires, and sheaths. The anesthesia segment of Teleflex includes products such as ventilation bags, endotracheal tubes, and nebulizer systems. These products are essential for the successful performance of anesthesia procedures and can help doctors save valuable time and resources. The oncology segment of Teleflex offers a wide range of products specifically designed for the treatment of cancer patients. These include catheter-based systems that can facilitate the administration of drugs and other therapies. With the vascular intervention segment, Teleflex offers a comprehensive range of products and solutions specifically designed for the treatment of vascular diseases. These include balloon catheters, stents, and sheaths. The pulmonology segment of Teleflex offers products aimed at facilitating breathing and improving the quality of life for patients with chronic respiratory diseases. These include oxygen concentrators, tracheal tubes, and ventilators. The surgical segment of Teleflex offers a variety of solutions for performing surgical procedures, including surgical instruments, sutures, and wound care materials. The urology segment of Teleflex offers a wide range of products specifically designed for use in urology. These include catheters, wires, and stents. Teleflex is a leading company in the medical technology industry that specializes in the development and marketing of products that improve patients' quality of life and facilitate the work of doctors. With its innovative solutions and a focus on providing the best possible customer service and patient safety, Teleflex has taken on a significant role in the industry and will continue to be an important provider in this market in the future. Teleflex adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Teleflex

Rule of 40 Teleflex adalah -21,77 % pada tahun 2026.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Rule of 40 Teleflex sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Rule of 40 menyatakan bahwa tingkat pertumbuhan pendapatan perusahaan ditambah margin laba harus melebihi 40%. Ini banyak digunakan untuk mengevaluasi perusahaan SaaS dan pertumbuhan tinggi.

Access this data via the Eulerpool API

Kualitas — Teleflex

Semua Metrik Kunci — Teleflex